Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FB9QN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,014
Award facts
- Contract value 100% obligated
- $15,013.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $15,013.79, awards Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) a firm fixed-price contract for 90 tablets of Jardiance 25 mg, a diabetes medication commonly used in military and veteran healthcare settings. The contract was awarded on January 13, 2026, with an ultimate completion date of January 14, 2026, and was performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively awarded transaction funded by the Defense Logistics Agency, which procures medical supplies and pharmaceuticals for the Department of Defense healthcare systems.
This delivery order was issued under Amerisourcebergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement (valued through December 2026) that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The parent company, Cencora, Inc., holds an even larger IDC with the Defense Logistics Agency valued up to $999.99 billion through December 31, 2031. The firm's extensive federal contract portfolio demonstrates its capability to efficiently fulfill government requirements for essential pharmaceutical commodities across multiple therapeutic domains, supporting military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FB9QN?
SPE2DR26FB9QN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FB9QN worth?
The government has obligated $15,014 on SPE2DR26FB9QN.
Is contract SPE2DR26FB9QN an order under another contract?
Yes. SPE2DR26FB9QN is a delivery order under SPE2DR25D2212, an indefinite delivery contract.
Was contract SPE2DR26FB9QN competed?
The extent of competition for SPE2DR26FB9QN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award